Eunice Yuen

5PUBLICATIONS
63CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2026
Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential.

|Mar 05, 2025
Postmarketing Assessment of Antibody-Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach.

Innocent Gerald Asiimwe, Nour Chtiba, Samer Mouksassi

|Dec 09, 2024
Imlunestrant Is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wild-Type and Mutant Breast Cancer.

Shripad V Bhagwat, Cecilia Mur, Matthew Vandekopple

|Oct 08, 2024
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study.

Patrick Neven, Nicole Stahl, Maria Vidal

|Dec 13, 2018
Evaluation of the effects of an oral notch inhibitor, crenigacestat (LY3039478), on QT interval, and bioavailability studies conducted in healthy subjects.

Eunice Yuen, Maria Posada, Claire Smith

Pageof 1

Frequent Collaborators

2 joint publications

Vivian Rodriguez Cruz

2 joint publications

Vanessa Rodrik-Outmezguine

2 joint publications

Roohi Ismail-Khan

1 joint publications

Stephen David Hall